Gene · 23462
Papers3,005
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,005
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond the bulk: overview and novel insights into the dynamics of muscle satellite cells during muscle regeneration. | Inflamm Regen | 2024 | 39327631 | PubTator, text mining | PubMed |
| The missing link between cancer stem cells and immunotherapy. | Curr Med Res Opin | 2024 | 39316769 | PubTator, text mining | PubMed |
| Different estimation techniques and data analysis for constant-partially accelerated life tests for power half-logistic distribution. | Sci Rep | 2024 | 39242750 | PubTator, text mining | PubMed |
| Case report: A mesenchymal chondrosarcoma with alternative HEY1::NCOA2 fusions in the sella turcica. | Pathol Oncol Res | 2024 | 39165647 | PubTator, text mining | PubMed |
| Distinctive field effects of smoking and lung cancer case-control status on bronchial basal cell growth and signaling. | Respir Res | 2024 | 39160511 | PubTator, text mining | PubMed |
| The Impact of Chemical Modifications on the Interferon-Inducing and Antiproliferative Activity of Short Double-Stranded Immunostimulating RNA. | Molecules | 2024 | 38999177 | PubTator, text mining | PubMed |
| [The Role of Notch Signaling Pathway in Adult Patients with Epstein-Barr Virus-induced Infectious Mononucleosis]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 38926989 | PubTator, text mining | PubMed |
| Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice. | Biol Res | 2024 | 38915069 | PubTator, text mining | PubMed |
| In vitro modulation the Notch pathway by piperine: A therapeutic strategy for docetaxel-resistant and non-resistant prostate cancer. | Chem Biol Drug Des | 2024 | 38898371 | PubTator, text mining | PubMed |
| Modulation of Epithelial-Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel. | Biomedicines | 2024 | 38790973 | PubTator, text mining | PubMed |
| rhBMP-2 induces terminal differentiation of human bone marrow mesenchymal stromal cells only by synergizing with other signals. | Stem Cell Res Ther | 2024 | 38679735 | PubTator, text mining | PubMed |
| Quiescent Adult Neural Stem Cells: Developmental Origin and Regulatory Mechanisms. | Neurosci Bull | 2024 | 38656419 | PubTator, text mining | PubMed |
| Management of corneal neovascularization: Current and emerging therapeutic approaches. | Indian J Ophthalmol | 2024 | 38648452 | PubTator, text mining | PubMed |
| Inhibition of Notch3/Hey1 ameliorates peribiliary hypoxia by preventing hypertrophic hepatic arteriopathy in biliary atresia progression. | Histochem Cell Biol | 2024 | 38597939 | PubTator, text mining | PubMed |
| Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. | Protein Cell | 2024 | 38437016 | PubTator, text mining | PubMed |
| Polyethylenimine Triggers Dll4 Degradation to Regulate Angiogenesis In Vitro. | ACS Omega | 2024 | 38405519 | PubTator, text mining | PubMed |
| Periosteum Containing Implicit Stem Cells: A Progressive Source of Inspiration for Bone Tissue Regeneration. | Int J Mol Sci | 2024 | 38396834 | PubTator, text mining | PubMed |
| Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells. | Circulation | 2024 | 38357822 | PubTator, text mining | PubMed |
| Meta-analysis of microarray data to determine gene indicators involved in cisplatin resistance in non-small cell lung cancer. | Cancer Rep (Hoboken) | 2024 | 38351531 | PubTator, text mining | PubMed |
| Hyperoxic ventilatory response in infants is related to nocturnal hypoxaemia. | ERJ Open Res | 2024 | 38333650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23462/papers?page=6